Albert David Limited
Incorporated in 1938, Albert DavidLtd is in the business of manufacturing pharmaceutical products
What Albert files
- Others76
- Board Meeting14
- Important10
- Results6
- Updates5
- Dividend/Bonus4
Albert David Ltd. has dispatched web-links for its FY 2025-26 Annual Report. The 87th Annual General Meeting will be held virtually. Shareholders are encouraged to update their KYC details, including email IDs, for better communication.
Company appoints Amit Mahla as CEO. Board approved FY26 financial results and proposes a final dividend of Rs. 5.00 per share, subject to shareholder approval. AGM scheduled.
Albert David appointed Amit Mahla as CEO and approved financial results for the quarter and full year. The board declared a final dividend of Rs. 5.00 per share. The 87th Annual General Meeting is planned.
Company appointed Amit Mahla as CEO. Board approved financial results for the quarter and financial year. A Rs 5/share (50%) final dividend was proposed, subject to shareholder approval. The 87th AGM is scheduled.
Board approved audited financial results for the quarter and financial year. Amit Mahla, a seasoned pharma leader with 28 years experience, appointed CEO. A final dividend of Rs.5.00/share was proposed, subject to shareholder approval.